| Revenue growth | FY26 growth at 16% YoY; Q4 growth at 10% YoY. |
|---|---|
| Margins | FY26 EBITDA margin at 26.2%; Q4 margin at 26.8%. |
| Demand visibility | Strong, with network occupancy maintained above 75% despite capacity additions. |
| Management confidence | High confidence in North India demand and brownfield expansion leverage. |
Growth
FY26 gross revenue reached INR 10,538 Cr (+16% YoY) with operating EBITDA growing 14% to INR 2,638 Cr.
Outlook
Investing INR 1,400 Cr in 700-bed Lucknow hospital; targeting 500-bed Gurgaon commissioning by end of FY27.
Risks
Discontinuation of high-value chemo drugs impacted oncology revenues; ALOS temporarily higher due to capacity rollouts.
Earnings Call filed with NSE, NSE: MAXHEALTH. Summary written with AI assistance from the document.
Max Healthcare Institute Ltd: key numbers
- Share price
- ₹1,014.00
- Market cap
- ₹98,694 Cr
- Revenue (annual)
- ₹8,373 Cr
- Net profit (annual)
- ₹1,442 Cr
- P/E (TTM)
- 67.7×Sector 57.8×
- Promoter holding
- 23.71%+0.00% QoQ
- FII holding
- 41.78%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Max Healthcare Institute Ltd
All →Max Healthcare Institute Annual General Meeting
Max Healthcare Institute Ltd issued a postal ballot notice to seek shareholder approval for its 2026 ESOP scheme, director remuneration, and alterations to its objects clause.
Max Healthcare Institute Other Announcement
Max Healthcare has received an ESG rating of '72' from Niche99, a SEBI-registered provider. This independent rating places the company in the 'Leader' category.
Max Healthcare Institute Legal & Regulatory
Max Healthcare disclosed an update on ongoing NCLT proceedings initiated by BRS Capital against its subsidiary. The next hearing is scheduled for September 28, 2026.
Max Healthcare Institute Employee Stock Options
Max Healthcare Institute Limited has allotted 33,765 equity shares under its ESOP scheme. This increases the total paid-up share capital to 973,310,251 equity shares.
Max Healthcare Institute Employee Stock Options
Max Healthcare allotted 33,765 equity shares under its Employee Stock Option Scheme 2022. The allotment was made at an exercise price of ₹350 per share.
- Value
- ₹1.18 Cr
Max Healthcare Institute Acquisition Worth ₹87.87 Cr
Max Healthcare Institute Limited approved an additional investment of Rs. 87.87 Crore in its subsidiary, Kalinga Hospital Limited. The funds will support capital expenditure and modernization programs.
- Value
- ₹87.87 Cr
- Execution
- Within next 15 days